Artelon
Marietta, US · Founded 2023 · Delaware corporation · 1 known investors
Artelon develops FLEXBAND, an elastic soft-tissue implant used to repair and augment tissue such as ankle ligaments, designed to maintain tension during motion and integrate into regenerating tissue over time. The company, now part of Stryker, operates in the orthopedic medical device field.
Founders & leadership
GB
Greg BankerDirector
AS
Aaron SmithExecutive Officer, Director
MC
Mark CohenDirector
JB
Jeff ByrneExecutive Officer
CM
Carter MeyerDirector
KN
Kirk NielsenDirector
SB
Steve BeckerDirector
GB
Gary BurbachDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$20MraisedJun 2023 · 1 investors · BiotechnologyRule 506(b)
▶$20MraisedJun 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Greg BankerDirector
- Aaron SmithExecutive Officer, Director
- Mark CohenDirector
- Jeff ByrneExecutive Officer
- Carter MeyerDirector
- Kirk NielsenDirector
- Steve BeckerDirector
- Gary BurbachDirector
- Offering amount
- $30M
- Amount sold
- $20M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.